|
|
|
|
||
Luspatercept MDS approval (hopefully) this weekend and news on Monday before the bellThe gyration in XLRN price (which is 90% owned by institutional holders; 13% by BMY; then add insiders and retail holders like me) is unbelievable. One needs super thick skin to hold on to XLRN. Same with TGTX. So owning these 2 plus SGMO ZIOP PGEN in addition to some other biotech companies is tough these days! Thank God for Farm Heroes Super Saga! |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
2190 | Re: Luspatercept MDS approval (hopefully) this weekend and news on Monday before the bell | Cordari30 | 1 | 4/2/2020 11:19:42 AM |